Trial Profile
Clinical Trials Insight: 700046615
Status:
Not stated
Phase of Trial:
Phase I
Latest Information Update: 17 Sep 2010
Price :
$35
*
At a glance
- Drugs Donepezil (Primary)
- Indications Alzheimer's disease
- Focus Pharmacokinetics
- Sponsors Teikoku Pharma USA
- 17 Sep 2010 The USA FDA has accepted the New Drug Application for the weekly, transdermal patch formulation of donepezil (Aricept) for review, according to a Teikoku Pharma USA Inc media release.
- 17 Sep 2010 The USA FDA has accepted for review the New Drug Application (NDA) for the weekly, transdermal patch formulation of donepezil, according to an Eisai Pharmaceuticals media release.
- 10 Jul 2009 New trial record.